Reference : Effects of a single 5 mg infusion of zoledronic acid and oral risedronate (5 mg/day) ...
Scientific congresses and symposiums : Paper published in a journal
Human health sciences : General & internal medicine
Human health sciences : Public health, health care sciences & services
Human health sciences : Rheumatology
http://hdl.handle.net/2268/83165
Effects of a single 5 mg infusion of zoledronic acid and oral risedronate (5 mg/day) on bone remodeling over one year in patients with glucocorticoid-induced osteoporosis
English
Saag, K. G. [ > > ]
Devogelaer, Jean-Pierre [ > > ]
Reid, D. M. [ > > ]
Sambrook, P. [ > > ]
Goemaere, S. [ > > ]
Ish-Shalom, S. [ > > ]
Collette, Julien mailto [Université de Liège - ULg > > Secteur dispatching >]
Papanastasiou, P. [ > > ]
Ferreira, A. [ > > ]
Eriksen, E. F. [ > > ]
Fashola, T. [ > > ]
Schoenborn-Kellenberger, O. [ > > ]
Chappard, D. [ > > ]
Reginster, Jean-Yves mailto [Université de Liège - ULg > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
Jun-2008
Annals of the Rheumatic Diseases
BMJ Group
67
Suppl.II
542
Yes (verified by ORBi)
No
International
0003-4967
1468-2060
London
United Kingdom
Congress of the European League Against Rheumatism (EULAR 2008)
du 11 juin 2008 au 14 juin 2008
European League Against Rheumatism
Paris
France
http://hdl.handle.net/2268/83165

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Open access
SAT0347.pdfPublisher postprint97.27 kBView/Open

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.